RTI Biologics Reports $45.2M 2Q Revenue, Up 4% FeaturedWritten by Jaimie Oh | August 03, 2012
RTI Biologics, a provider of orthopedic and other biologic implants, reported quarterly revenues of $45.2 million, a 4 percent increase over the second quarter of 2011.
The company's surgical specialties business quarterly revenues reached $8.5 million, an 18 percent increase, while its bone graft substitutes and general orthopedic business quarterly revenues reached $7.0 million, a 12 percent increase. RTI Biologics' sports medicine business line also achieved $13.3 million, a 10 percent increase over the second quarter of 2011.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.